One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...

People with the rare Li-Fraumeni syndrome (LFS) have a high risk of developing cancer. Almost all those affected will develop ...

Women are being encouraged to seize the opportunity for a potentially life-saving NHS appointment. Anyone can take advantage ...

During a Case-Based Roundtable® event, John N. Allan, MD, discussed how new regimens using BTK inhibitors and venetoclax ...

A first-ever analysis of the whole Greenland shark genome gives researchers a couple of clues to their longevity.

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

Actinium Pharmaceuticals (ATNM) has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center to expand ...

Researchers have discovered race-associated molecular differences in tumors that may impact the way patients with pancreatic ...

A new study examines cancer prevalence across hundreds of vertebrate species. Every multicellular creature, whether soaring ...

Actinium Pharma inks research pact with Memorial Sloan Kettering to support further clinical expansion of Actimab-A's backbone therapy strategy: New York Saturday, March 22, 2025, ...

A study of 200 patients with chronic lymphocytic leukemia (CLL) showed a lower rate of severe and serious adverse events ...

An app told Brian O'Sullivan he had cancer. 'And that started my love-hate relationship with technology,' he says.